Insights

Unique mRNA technology Strand Therapeutics leverages its innovative mRNA programming technology to develop smart therapies that can precisely control therapeutic protein expression within a patient's body. This unique approach offers a competitive edge by promising safer and more effective mRNA therapies.

Financial backing Recent investments totaling $97 million in Series A funding indicate strong investor confidence in Strand Therapeutics. This financial backing not only supports the company's growth but also presents an opportunity for partnership or collaboration with investors looking to expand their presence in the biotechnology sector.

Strategic talent acquisition Strand Therapeutics' strategic hires of experienced professionals like the Chief People Officer and Chief Business Officer demonstrate a focus on building a robust leadership team. Leveraging the expertise of these key personnel can open doors to networking opportunities or strategic alliances with other industry experts.

Competitive positioning In a landscape with similar biotech companies, Strand Therapeutics stands out with its unique mRNA programming platform. By highlighting the advantages of their technology compared to competitors, sales development representatives can position the company as a top choice for potential partners seeking cutting-edge solutions in the biotechnology space.

Expansion potential With a growing team of 51-200 employees and a revenue range of $10-50 million, Strand Therapeutics has the resources and momentum to consider expanding its market reach or exploring new opportunities for product development. Sales professionals can tap into this growth trajectory to explore potential sales opportunities in new geographies or verticals.

Strand Therapeutics Tech Stack

Strand Therapeutics uses 8 technology products and services including Google Hosted Libraries, MySQL, MariaDB, and more. Explore Strand Therapeutics's tech stack below.

  • Google Hosted Libraries
    Content Delivery Network
  • MySQL
    Database
  • MariaDB
    Database
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Java
    Programming Languages
  • Linux
    Programming Languages
  • Cloudflare Bot Management
    Security

Media & News

Strand Therapeutics's Email Address Formats

Strand Therapeutics uses at least 1 format(s):
Strand Therapeutics Email FormatsExamplePercentage
First.Last@strandtx.comJohn.Doe@strandtx.com
98%
Last@strandtx.comDoe@strandtx.com
1%
First.L@strandtx.comJohn.D@strandtx.com
1%

Frequently Asked Questions

Where is Strand Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Strand Therapeutics's main headquarters is located at 21-27 Burlington Ave Boston, Massachusetts 02215 US. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is Strand Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Strand Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Strand Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Strand Therapeutics's official website is strandtx.com and has social profiles on LinkedIn.

How much revenue does Strand Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Strand Therapeutics's annual revenue reached $15M.

What is Strand Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Strand Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Strand Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Strand Therapeutics has approximately 93 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Business Officer: J. S.Chief Operating Officer: S. K.Chief People Officer: C. W.. Explore Strand Therapeutics's employee directory with LeadIQ.

What industry does Strand Therapeutics belong to?

Minus sign iconPlus sign icon
Strand Therapeutics operates in the Biotechnology Research industry.

What technology does Strand Therapeutics use?

Minus sign iconPlus sign icon
Strand Therapeutics's tech stack includes Google Hosted LibrariesMySQLMariaDBjQueryOpen GraphJavaLinuxCloudflare Bot Management.

What is Strand Therapeutics's email format?

Minus sign iconPlus sign icon
Strand Therapeutics's email format typically follows the pattern of . Find more Strand Therapeutics email formats with LeadIQ.

How much funding has Strand Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, Strand Therapeutics has raised $45M in funding. The last funding round occurred on Nov 28, 2022 for $45M.

When was Strand Therapeutics founded?

Minus sign iconPlus sign icon
Strand Therapeutics was founded in 2017.
Strand Therapeutics

Strand Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Strand was founded by biological  engineers working together at the Massachusetts Institute of Technology (MIT). Building on the  idea of creating smart therapies  capable of making sophisticated decisions, they sought to apply this  concept to the emerging field  of  mRNA therapeutics. This area was  previously untapped by traditional  synthetic biology, leading us to  build our very own mRNA programming language, creating  the world’s first platform for mRNA  smart therapies.  

Strand’s mRNA programming  technology promises to make  mRNA therapies safer and more  effective by programming the  location, timing, and intensity of  therapeutic protein expression inside a patient’s body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.

Section iconCompany Overview

Headquarters
21-27 Burlington Ave Boston, Massachusetts 02215 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $45M

    Strand Therapeutics has raised a total of $45M of funding over 6 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $45M.

  • $10M$50M

    Strand Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $45M

    Strand Therapeutics has raised a total of $45M of funding over 6 rounds. Their latest funding round was raised on Nov 28, 2022 in the amount of $45M.

  • $10M$50M

    Strand Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.